We are live on ! Find out more
MMH

Menora Mivtachim Holdings Portfolio holdings

AUM $21.1B
1-Year Est. Return 40.03%
This Fund
S&P 500
This Quarter Est. Return
+6.45%
1 Year Est. Return
+40.03%
3 Year Est. Return
+110.3%
5 Year Est. Return
+129.3%
10 Year Est. Return
+734.74%
AUM
$1.95B
AUM Growth
+$130M
Cap. Flow
+$31.4M
Cap. Flow %
1.61%
Top 10 Hldgs %
46.02%
Holding
118
New
37
Increased
20
Reduced
27
Closed
7

Top Buys

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$42.7M
2
PM icon
Philip Morris
PM
+$19.9M
3
MDT icon
Medtronic
MDT
+$17.5M
4
AMZN icon
Amazon
AMZN
+$13.4M
5
KITE
Kite Pharma, Inc.
KITE
+$12.3M

Top Sells

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$56.9M
2
PRGO icon
Perrigo
PRGO
+$26.7M
3
BAC icon
Bank of America
BAC
+$25.3M
4
WFC icon
Wells Fargo
WFC
+$22.2M
5
C icon
Citigroup
C
+$17.4M

Sector Composition

Rank Sector Weight
1 Financials 22.44%
2 Communication Services 19.81%
3 Healthcare 19.5%
4 Industrials 11.57%
5 Technology 10.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRK icon
51
Merck
MRK
$318B
$5.9M 0.3%
105,005
-240,208
-70% -$14.1M
IMPV
52
DELISTED
Imperva, Inc.
IMPV
$5.57M 0.29%
145,000
URI icon
53
United Rentals
URI
$72.4B
$5.56M 0.29%
+52,700
New +$4.8M
GD icon
54
General Dynamics
GD
$106B
$5.16M 0.26%
+29,900
New +$4.89M
OC icon
55
Owens Corning
OC
$12.4B
$4.98M 0.26%
+96,500
New +$5M
TT icon
56
Trane Technologies
TT
$106B
$4.88M 0.25%
+65,000
New +$4.69M
RDHL
57
Redhill Biopharma
RDHL
$3.68M
$4.4M 0.23%
421
+175
+71% +$2.1M
ELOS
58
DELISTED
Syneron Medical Ltd
ELOS
$4.32M 0.22%
514,746
TTEK icon
59
Tetra Tech
TTEK
$9.07B
$3.43M 0.18%
+397,000
New +$3.21M
MZOR
60
DELISTED
Mazor Robotics Ltd.
MZOR
$3.29M 0.17%
150,000
+100,000
+200% +$2.25M
ALLT icon
61
Allot
ALLT
$383M
$3.06M 0.16%
638,039
-10,500
-2% -$52.5K
RTX icon
62
RTX Corp
RTX
$301B
$1.74M 0.09%
25,235
-20,463
-45% -$1.36M
EVGN icon
63
Evogene
EVGN
$7.26M
$1.32M 0.07%
25,884
ELLO icon
64
Ellomay Capital Ltd
ELLO
$271M
$1.17M 0.06%
145,090
CCJ icon
65
Cameco
CCJ
$42.4B
$1.15M 0.06%
109,400
+95,000
+660% +$858K
ITRN icon
66
Ituran Location and Control
ITRN
$1.05B
$842K 0.04%
31,783
CS
67
DELISTED
Credit Suisse Group
CS
$802K 0.04%
56,000
-60,100
-52% -$842K
PNTR
68
DELISTED
Pointer Telocation Ltd.
PNTR
$759K 0.04%
111,605
-2,746
-2% -$20.5K
MDWD icon
69
MediWound
MDWD
$185M
$742K 0.04%
23,161
GE icon
70
GE Aerospace
GE
$384B
$629K 0.03%
4,152
-4,278
-51% -$621K
CSTE icon
71
Caesarstone
CSTE
$79.5M
$610K 0.03%
+21,000
New +$667K
KMDA icon
72
Kamada
KMDA
$419M
$511K 0.03%
93,800
APC
73
DELISTED
Anadarko Petroleum
APC
$439K 0.02%
6,300
-13,207
-68% -$859K
ASIX icon
74
AdvanSix
ASIX
$444M
$318K 0.02%
+14,348
New +$258K
SBUX icon
75
Starbucks
SBUX
$120B
$305K 0.02%
5,500
-3,780
-41% -$209K

Similar funds

Menora Mivtachim Holdings's Q4 2016 Portfolio in Review

As of Q4 2016, Menora Mivtachim Holdings held 118 positions worth $1.95B, up 7.2% from $1.82B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Menora Mivtachim Holdings's Q4 2016 filing shows 37 new, 20 increased, 27 reduced and 7 closed positions. Its largest new stake was Philip Morris: 215,000 shares worth $19.7M. The largest sale was JPMorgan Chase, an estimated $56.9M.

By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 25% a quarter earlier, followed by Communication Services and Healthcare.

  • Menora Mivtachim Holdings's largest Q4 2016 buy was Philip Morris: 215,000 shares worth $19.7M.
  • Menora Mivtachim Holdings added most to Teva Pharmaceuticals in Q4 2016, an estimated $42.7M increase.
  • Menora Mivtachim Holdings's biggest Q4 2016 reduction was JPMorgan Chase, cutting an estimated $56.9M.
  • Menora Mivtachim Holdings fully exited PepsiCo in Q4 2016, selling an estimated $1.43M.
  • Menora Mivtachim Holdings's ten largest holdings make up 46% of its $1.95B portfolio in Q4 2016.
  • Menora Mivtachim Holdings opened 37 new positions and closed 7 in Q4 2016.
  • Menora Mivtachim Holdings's portfolio value rose 7.2% quarter-over-quarter to $1.95B.

Based on Menora Mivtachim Holdings's 13F filing for Q4 2016, filed 15 Feb 2017.